Literature DB >> 22798027

Circadian entrainment and its role in depression: a mechanistic review.

G S Lall1, L A Atkinson, S A Corlett, P J Broadbridge, D R Bonsall.   

Abstract

The natural rotation of the earth generates an environmental day-night cycle that repeats every 24 h. This daily transition from dawn to dusk provides one of the most important time cues to which the majority of organisms synchronise their activity. Under these conditions, natural light, a photic stimulus, provides the principal entraining cue. In mammals, an endogenous circadian pacemaker located within the suprachiasmatic nucleus (SCN) of the hypothalamus acts as a coordinating centre to align physiological activity with the environmental light-dark cycle. However, the SCN also receives regulatory input from a number of behavioural, non-photic, cues such as physical activity, social interactions and feeding routines. The unique ability of the SCN to integrate both photic and non-photic cues allows it to generate a rhythm that is tailored to the individual and entrained to the environment. Here, we review the key neurotransmitter systems involved in both photic and non-photic transmission to the SCN and their interactions that assist in generating an entrained output rhythm. We also consider the impact on health of a desynchronised circadian system with a focus on depressive affective disorders and current therapies aimed at manipulating the relationship between photic and non-photic SCN regulators.

Entities:  

Mesh:

Year:  2012        PMID: 22798027     DOI: 10.1007/s00702-012-0858-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  145 in total

1.  Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo.

Authors:  E M Mintz; C L Marvel; C F Gillespie; K M Price; H E Albers
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Circadian rhythm phase advance with dawn simulation treatment for winter depression.

Authors:  Michael Terman
Journal:  J Biol Rhythms       Date:  2010-08       Impact factor: 3.182

3.  Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.

Authors:  Stephanie J Soscia; Mary E Harrington
Journal:  Neurosci Lett       Date:  2004-12-16       Impact factor: 3.046

4.  Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.

Authors:  R C Kessler; C B Nelson; K A McGonagle; J Liu; M Swartz; D G Blazer
Journal:  Br J Psychiatry Suppl       Date:  1996-06

Review 5.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

6.  A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder.

Authors:  Adam Moscovitch; Carl A Blashko; John M Eagles; Guy Darcourt; Christopher Thompson; Siegfried Kasper; Roger M Lane
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

7.  REM latency: a psychobiologic marker for primary depressive disease.

Authors:  D J Kupfer
Journal:  Biol Psychiatry       Date:  1976-04       Impact factor: 13.382

Review 8.  Chronotherapeutics in a psychiatric ward.

Authors:  Francesco Benedetti; Barbara Barbini; Cristina Colombo; Enrico Smeraldi
Journal:  Sleep Med Rev       Date:  2007-08-03       Impact factor: 11.609

9.  A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression.

Authors:  B Claustrat; G Chazot; J Brun; D Jordan; G Sassolas
Journal:  Biol Psychiatry       Date:  1984-08       Impact factor: 13.382

10.  Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice.

Authors:  S Hattar; R J Lucas; N Mrosovsky; S Thompson; R H Douglas; M W Hankins; J Lem; M Biel; F Hofmann; R G Foster; K-W Yau
Journal:  Nature       Date:  2003-06-15       Impact factor: 49.962

View more
  6 in total

1.  Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: A pilot study.

Authors:  Rachel E Fargason; Aaron D Fobian; Lauren M Hablitz; Jodi R Paul; Brittny A White; Karen L Cropsey; Karen L Gamble
Journal:  J Psychiatr Res       Date:  2017-03-06       Impact factor: 4.791

2.  CRTC2 activation in the suprachiasmatic nucleus, but not paraventricular nucleus, varies in a diurnal fashion and increases with nighttime light exposure.

Authors:  Julie A Highland; Michael J Weiser; Laura R Hinds; Robert L Spencer
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-30       Impact factor: 4.249

3.  Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions.

Authors:  Amanda N Carey; Xiaoxu Liu; Dionyssios Mintzopoulos; Jason J Paris; John W Muschamp; Jay P McLaughlin; Marc J Kaufman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-12-23       Impact factor: 5.067

Review 4.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

5.  Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity.

Authors:  Jonathan Shelton; Sujin Yun; Susan Losee Olson; Fred Turek; Pascal Bonaventure; Curt Dvorak; Timothy Lovenberg; Christine Dugovic
Journal:  Front Behav Neurosci       Date:  2015-01-15       Impact factor: 3.558

6.  The sleep and circadian modulation of neural reward pathways: a protocol for a pair of systematic reviews.

Authors:  Jamie E M Byrne; Greg Murray
Journal:  Syst Rev       Date:  2017-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.